Magellan Health (MGLN) Tops Q3 EPS Views; Boosts FY14 EPS Outlook

Magellan Health (NASDAQ: MGLN) reported Q3 adjusted EPS of $1.30, $0.83 better than the analyst estimate of $0.47. Revenue for the quarter came in at $823.2 million versus the consensus estimate of $930.1 million.

Magellan Health sees FY2014 EPS of $3.21-$3.72, versus the consensus of $2.16. Magellan Health sees FY2014 revenue of $3.6-3.8 billion, versus the consensus of $3.79 billion.

For earnings history and earnings-related data on Magellan Health (MGLN) click here.

You May Also Be Interested In

• Walmart (WMT) PT Lowered to $130 at UBS on Investment Narrative's Competing Dynamics
• Intchains Group Ltd (ICG) PT Lowered to $2 at Benchmark Following 1H Results
• Beike (BEKE) PT Raised to $23 at Morgan Stanley